2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission

Vernalis Research Limited 2000. 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission. WO2000044371A1. [Patent].

Full text not available from this repository.

Abstract

The use of a compound of formula (1), wherein R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen, alkyl and aryl, or pharmaceutically acceptable salts thereof, with the proviso that wherein R1 to R4 and R6 are hydrogen, R5 is not selected from CH2CH2NHSO2CH3, CH2CH2NHSO2CF3 and methyl substituted by SO2NH2, SO3H, PO3H2, CONHOH or a heterocyclic group selected from formulae (a), (b), (c), (d) and (e) in the manufacture of a medicament for use in the treatment of a condition generally associated with abnormalities in glutamatergic transmission.

Item Type:	Patent
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	2-adamantanemethanamine compounds
Last Modified:	25 Oct 2022 13:17
URI:	https://orca.cardiff.ac.uk/id/eprint/119392

Actions (repository staff only)

Edit Item